Table Of Contents
1 Introduction 30
1.1 Objectives Of The Study 30
1.2 Market Definition 30
1.3 Overview Of Middle East-And Africa Wound Care Biologics Market 30
1.4 Currency And Pricing 31
1.5 Limitation 31
1.6 Markets Covered 32
2 Market Segmentation 34
2.1 Markets Covered 34
2.2 Geographic Scope 35
2.3 Years Considered For The Study 36
2.4 Currency And Pricing 36
2.5 Research Methodology 37
2.6 Primary Interviews With Key Opinion Leaders 40
2.1 Dbmr Market Position Grid 41
2.2 Dbmr Market Challenge Matrix 42
2.3 Secondary Sources 43
2.4 Assumptions 43
3 Market Overview 44
3.1 Drivers 46
3.1.1 Increasing Cases Of Diabetic Foot Ulcers 46
3.1.2 Increasing Incidences Of Burn Cases 46
3.1.3 Rising Number Of Geriatric Population 47
3.1.4 Innovation In Wound Care Biologics 48
3.1.5 New Product Launches 50
3.2 Restrains 50
3.2.1 High Cost Of Wound Treatment And Wound Care Biologics 50
3.2.2 Risk Of Skin Substitue Failure 51
3.3 Opportunities 52
3.3.1 3D Skin Printing 52
3.3.2 Awareness Programs 53
3.4 Challenges 54
3.4.1 Lack Of Wound Management Services 54
4 Executive Summary 55
5 Premium Insights 58
6 Middle East-And Africa Wound Care Biologics Market, By Product Type 63
6.1 Overview 64
6.2 Synthetic Skin Grafts 66
6.3 Growth Factors 67
6.3.1 Platelet Derived Growth Factor (Pdgf) 70
6.3.2 Platelet Rich Plasma (Prp) 70
6.3.3 Epidermal Growth Factors (Egf) 70
6.3.4 Basic Fibroblast Growth Factors (Bfgf) 71
6.3.5 Granulocyte Colony Stimulating Factor (G-Csf) 71
6.3.6 Talactoferrin Alfa 71
6.3.7 Thrombin Peptide 72
6.3.8 Keratinocy Growth Factor (Kgf) 72
6.4 Allografts 73
6.5 Xenografts 74
7 Middle East-And Africa Wound Care Biologics Market, By Wound Type 76
7.1 Overview 77
7.2 Wounds 78
7.2.1 Surgical Wound 80
7.2.1.1 Skin Surgery 81
7.2.1.1.1 Wound Closure 82
7.2.1.1.2 Skin Biopsy 82
7.2.1.1.3 Skin Flap 82
7.2.1.1.4 Skin Graft 82
7.2.1.1.5 Others 82
7.2.1.2 Cosmetic Procedure 83
7.2.1.2.1 Brest Enhancement 84
7.2.1.2.2 Facial Contouring 85
7.2.1.2.3 Facial Rejuvenation; 85
7.2.1.2.4 Body Contouring 85
7.2.1.2.5 Skin Rejuvenation 85
7.2.1.2.6 Others 86
7.2.1.3 Gynecologic Procedures 86
7.2.1.3.1 Pubovaginalis Sling 86
7.2.1.3.2 Pelvic Floor Reconstruction 87
7.2.1.3.3 Rectocele Repair Surgery 87
7.2.1.3.4 Others 87
7.2.1.4 Gastrointestinal Procedure 87
7.2.1.4.1 General Gastrointestinal Surgery 88
7.2.1.4.2 Hernia 89
7.2.1.4.3 Others 89
7.2.2 Acute Wounds 90
7.2.3 Chronic Wounds 90
7.2.4 Traumatic Wounds 91
7.3 Burns 91
7.3.1 Ulcers 92
7.3.2 Diabetic Ulcers 94
7.3.3 Pressure Ulcer 94
7.3.4 Venous Ulcer 95
7.3.5 Others 95
8 Middle East-And Africa Wound Care Biologics Market, By End User 96
8.1 Overview 97
8.2 Hospitals 99
8.3 Wound Care Centers 100
8.4 Ambulatory Surgical Centers 101
8.5 Clinics 103
8.6 Community Healthcare Center 104
9 Middle East-And Africa Wound Care Biologics Market; Geography 105
9.1 Middle East & Africa 105
9.1.1 South Africa 116
9.1.2 Rest Of Middle East & Africa 123
10 Middle East-And Africa Wound Care Biologics Market, Company Landscape 124
10.1 Company Share Analysis; Middle East-And Africa 124
11 Company Profile 125
11.1 Mimedx. 125
11.1.1 Company Overview 125
11.1.2 Revenue Analysis; 125
11.1.3 Company Share Analysis; 126
11.1.4 Product Portfolio 126
11.1.5 Recent Developments 127
?
11.2 Organogenesis Inc 128
11.2.1 Company Overview 128
11.2.2 Geographic Presence 128
11.2.3 Company Share Analysis; 129
11.2.4 Product Portfolio 129
11.2.5 Recent Developments 130
11.3 Integra Lifesciences 131
11.3.1 Company Overview 131
11.3.2 Revenue Analysis 131
11.3.3 Company Share Analysis; 132
11.3.4 Product Portfolio 132
11.3.5 Recent Developments 133
11.4 Convatec Inc. 134
11.4.1 Company Overview 134
11.4.2 Revenue Analysis 134
11.4.3 Company Share Analysis; 135
11.4.4 Product Portfolio ; 135
11.4.5 Recent Developments 135
11.5 Acell Inc. 136
11.5.1 Company Overview 136
11.5.2 Product Portfolio 136
11.5.3 Recent Developments 137
11.6 Allosource 138
11.6.1 Company Overview 138
11.6.2 Product Portfolio 138
11.6.3 Recent Developments 139
11.7 Alphatec Spine, Inc. ( A Subsidary Of Alphatec Holdings, Inc) 140
11.7.1 Company Overview 140
11.7.2 Product Portfolio 140
11.7.3 Recent Developments 140
11.8 Amnio Technology, Llc 141
11.8.1 Company Overview 141
11.8.2 Product Portfolio 141
11.8.3 Recent Developments 142
11.9 Amniox Medical, Inc. 143
11.9.1 Company Overview 143
11.9.2 Product Portfolio 143
11.9.3 Recent Developments 144
11.10 Anika Therapeutics, Inc. 145
11.10.1 Company Overview 145
11.10.2 Revenue Analysis 145
11.10.3 Product Portfolio 146
11.10.4 Recent Developments 146
11.11 Biohorizons Iph, Inc ( A Subsidary Of Henry Schein, Inc.) 147
11.11.1 Company Overview 147
11.11.2 Geographicpresence 147
11.11.3 Product Portfolio 148
11.11.4 Recent Developments 148
11.12 Kerecis 149
11.12.1 Company Overview 149
11.12.2 Geographical Presence 149
11.12.3 Product Portfolio 150
11.12.4 Recent Developments 150
11.13 Marine Polymer Technologies, Inc 151
11.13.1 Company Overview 151
11.13.2 Product Portfolio 151
11.13.3 Recent Developments 151
11.14 M?lnlycke Health Care Ab 152
11.14.1 Company Overview 152
11.14.2 Revenue Analysis 152
11.14.3 Product Portfolio 153
11.14.4 Recent Developments 153
11.15 Osiris Therapeutics, Inc. 154
11.15.1 Company Overview 154
11.15.2 Revenue Analysis 154
11.15.3 Product Portfolio 155
11.15.4 Recent Developments 155
11.16 Skye Biologics Inc. 156
11.16.1 Company Overview 156
11.16.2 Product Portfolio ; 156
11.16.3 Recent Development; 157
11.17 Smith And Nephew 158
11.17.1 Company Overview 158
11.17.2 Revenue Analysis 158
11.17.3 Product Portfolio 159
11.17.4 Recent Developments 159
11.18 Solsys Medical. 160
11.18.1 Company Overview 160
11.18.2 Product Portfolio 161
11.18.3 Recent Developments 161
11.19 Vericel Corporation. 162
11.19.1 Company Overview 162
11.19.2 1.1.2 Revenue Analysis 162
11.19.3 Product Portfolio 163
11.19.4 Recent Developments 163
11.20 Wright Medical Group N.V 164
11.20.1 Company Overview 164
11.20.2 1.1.2 Revenue Analysis 164
11.20.3 Product Portfolio 165
11.20.4 Recent Developments 166
12 Related Reports 167
?